Skip to main content

Table 1 Background data and the effect of various potential risk factors on death related to MERS-CoV infection in morbid cases in the world

From: Current epidemiological status of Middle East respiratory syndrome coronavirus in the world from 1.1.2017 to 17.1.2018: a cross-sectional study

Characteristic

Subgroup

Frequency (%)

Number of deaths (%)

Crude OR [95% CI]

Adjusted OR [95% CI]

Age (year)

10-19a

8(3.5)

1(1.4)

1.00

1.00

20–29

18(7.9)

3(4.3)

0.7 [0.06, 8.15]

0.7 [0.06, 8.47]c

30–39

30(13.1)

4(5.7)

0.9 [0.08, 9.68]

0.9 [0.9, 10,24]c

40–49

30(13.1)

3(4.3)

1.2 [0.11, 14.33]

1.3 [0.11, 14.79]c

50–59

54(23.6)

20(28.6)

0.2 [0.02, 2.12]

0.2 [0.02, 2.31]c

60–69

42(18.3)

13(18.6)

0.3 [0.03, 2.86]

0.3 [0.03, 3.10]c

70–79

36(15.7)

20(28.6)

0.1 [0.01, 1.02]

0.1 [0.01, 1.07]c

80–89

11(4.8)

6(8.6)

0.1 [0.01, 1.32]

0.1 [0.01, 1.35]c

Sex

Male

171(74.7)

55(78.6)

0.7 [0.37, 1.43]

0.7 [0.38, 1.59]d

Female

58(25.3)

15(21.4)

Health care worker

Yes

25(10.9)

0(41.7)

0.6 [0.59, 0.72]

0.6 [0.49, 0.88]e

No

204(89.1)

70(34.3)

Comorbiditiesb

Yes

151(65.9)

63(41.7)

3.7 [1.58, 9.03]

2.2 [1.16, 7.03]f

No

44(19.2)

7(15.9)

Not available

34(14.8)

0(0.0)

Exposure to camels

Yes

77(33.6)

30(39.0)

2.1 [0.76, 5.90]

1.7 [.60, 5.05]f

No

26(11.4)

6(23.1)

Not available

126(55.0)

34(27.0)

Camel milk consumption

Yes

61(26.6)

25(41.0)

2.5 [0.90, 7.18]

2.0 [.68, 6.14]f

No

28(12.2)

6(21.4)

Not available

140(61.1)

39(27.9)

Exposure to MERS-CoV cases

Yes

59(25.8)

6(10.2)

3.3 [1.95, 7.35]

2.3 [1.35, 8.20]f

No

24(10.5)

10(41.7)

Not available

146(63.8)

54(37.0)

  1. a Was chosen as a reference age group
  2. b Diabetes, heart disease, chronic bronchitis and other chronic lung diseases
  3. cAdjusted for sex, dadjusted for sex, eadjusted for exposure to camels and exposure to MERS-CoV cases, fadjusted for age and sex